Search research articles
Contact Us
Filters
Showing results (121-130 of 156) with videos related to
Page
of 16
Sort By:
Blood
|
July 20, 2016
Treatment recommendations from the Eighth International Workshop on Waldenström's Macroglobulinemia
Véronique Leblond, Efstathios Kastritis, Ranjana Advani, et al.
Blood
|
January 18, 2006
Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemia
Steven P Treon, Morie A Gertz, Meletios Dimopoulos, et al.
Leukemia
|
May 24, 2019
A revised international prognostic score system for Waldenström's macroglobulinemia
Efstathios Kastritis, Pierre Morel, Alain Duhamel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 2012
Results of a randomized trial of chlorambucil versus fludarabine for patients with untreated Waldenström macroglobulinemia, marginal zone lymphoma, or lymphoplasmacytic lymphoma
Véronique Leblond, Steve Johnson, Sylvie Chevret, et al.
Communications Biology
|
October 7, 2022
SMAD2/3 mediate oncogenic effects of TGF-β in the absence of SMAD4
Adrien Bertrand-Chapel, Cassandre Caligaris, Tanguy Fenouil, et al.
American Journal of Hematology
|
June 16, 2026
The IL-10/IL-6 Ratio and the Risk Score: Two Cytokines-Based Predictors for Malignancy-Associated Hemophagocytic Lymphohistiocytosis in Adults (M-HLHa)
Coralie Bloch, Stephanie Chhun, Nanthara Sritharan, et al.
British Journal of Haematology
|
August 4, 2017
Transformed Waldenström macroglobulinaemia: clinical presentation and outcome. A multi-institutional retrospective study of 77 cases from the French Innovative Leukemia Organization (FILO)
Eric Durot, Cécile Tomowiak, Anne-Sophie Michallet, et al.
American Journal of Hematology
|
August 19, 2015
Lenalidomide is safe and active in Waldenström macroglobulinemia
Guillemette Fouquet, Stéphanie Guidez, Marie-Odile Petillon, et al.
Seminars in Hematology
|
May 22, 2025
Report of Consensus Panel 1 from the 12th International Workshop on the management of patients with IgM and Waldenstrom's Macroglobulinemia related neuropathy
Shirley D'Sa, Jahanzaib Khwaja, Signy Chow, et al.
Cancer Cell
|
September 14, 2013
p53 acts as a safeguard of translational control by regulating fibrillarin and rRNA methylation in cancer
Virginie Marcel, Sandra E Ghayad, Stéphane Belin, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 156) with videos related to
Sort By:
Page
of 16
Blood
|
July 20, 2016
Treatment recommendations from the Eighth International Workshop on Waldenström's Macroglobulinemia
Véronique Leblond, Efstathios Kastritis, Ranjana Advani, et al.
Blood
|
January 18, 2006
Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemia
Steven P Treon, Morie A Gertz, Meletios Dimopoulos, et al.
Leukemia
|
May 24, 2019
A revised international prognostic score system for Waldenström's macroglobulinemia
Efstathios Kastritis, Pierre Morel, Alain Duhamel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 2012
Results of a randomized trial of chlorambucil versus fludarabine for patients with untreated Waldenström macroglobulinemia, marginal zone lymphoma, or lymphoplasmacytic lymphoma
Véronique Leblond, Steve Johnson, Sylvie Chevret, et al.
Communications Biology
|
October 7, 2022
SMAD2/3 mediate oncogenic effects of TGF-β in the absence of SMAD4
Adrien Bertrand-Chapel, Cassandre Caligaris, Tanguy Fenouil, et al.
American Journal of Hematology
|
June 16, 2026
The IL-10/IL-6 Ratio and the Risk Score: Two Cytokines-Based Predictors for Malignancy-Associated Hemophagocytic Lymphohistiocytosis in Adults (M-HLHa)
Coralie Bloch, Stephanie Chhun, Nanthara Sritharan, et al.
British Journal of Haematology
|
August 4, 2017
Transformed Waldenström macroglobulinaemia: clinical presentation and outcome. A multi-institutional retrospective study of 77 cases from the French Innovative Leukemia Organization (FILO)
Eric Durot, Cécile Tomowiak, Anne-Sophie Michallet, et al.
American Journal of Hematology
|
August 19, 2015
Lenalidomide is safe and active in Waldenström macroglobulinemia
Guillemette Fouquet, Stéphanie Guidez, Marie-Odile Petillon, et al.
Seminars in Hematology
|
May 22, 2025
Report of Consensus Panel 1 from the 12th International Workshop on the management of patients with IgM and Waldenstrom's Macroglobulinemia related neuropathy
Shirley D'Sa, Jahanzaib Khwaja, Signy Chow, et al.
Cancer Cell
|
September 14, 2013
p53 acts as a safeguard of translational control by regulating fibrillarin and rRNA methylation in cancer
Virginie Marcel, Sandra E Ghayad, Stéphane Belin, et al.
Page
of 16